Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $135.9500 (2.38%) ($132.6000 - $138.7000) on Thu. Dec. 20, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.23% (three month average) | RSI | 25 | Latest Price | $135.9500(2.38%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND declines -0.9% a day on average for past five trading days. | Weekly Trend | LGND declines -7.8% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(59%) IWO(57%) XBI(55%) IWC(54%) IWM(52%) | Factors Impacting LGND price | LGND will decline at least -1.615% in a week (0% probabilities). TLT(-16%) VXX(-15%) VIXM(-11%) UUP(-9%) DIA(-9%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.615% (StdDev 3.23%) | Hourly BBV | 0 () | Intraday Trend | 2.5% | | | |
|
1 - 5 Day Possible Target | $124.38(-8.51%) | Resistance Level | $147.89 | 5 Day Moving Average | $134.33(1.21%) | 10 Day Moving Average | $139.87(-2.8%) | 20 Day Moving Average | $147.89(-8.07%) | To recent high | -50.5% | To recent low | 2.6% | Market Cap | $2.185b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |